4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-24-008979
Executive Vice President & CFO gave up 49,280 shares (to pay taxes)
- Executive Vice President & CFO acquired 138,826 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Konidaris Tasos Executive Vice President & CFO | 2024-03-01 | Option exercise | +36,197 | 417,037 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2024-03-01 | Shares withheld for taxes | −13,257 | $5.47 | $72,516 | 403,780 | D |
| Konidaris Tasos Executive Vice President & CFO | 2024-03-03 | Option exercise | +45,290 | 449,070 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2024-03-03 | Shares withheld for taxes | −15,897 | $5.47 | $86,957 | 433,173 | D |
| Konidaris Tasos Executive Vice President & CFO | 2024-03-03 | Option exercise | +57,339 | 490,512 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2024-03-03 | Shares withheld for taxes | −20,126 | $5.47 | $110,089 | 470,386 | D |
| Derivatives | |||||||
| Konidaris Tasos Executive Vice President & CFO | 2024-03-01 | Option exercise · Restricted Stock Units | −36,197 | 36,197 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2024-03-03 | Option exercise · Restricted Stock Units | −45,290 | 90,580 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2024-03-03 | Option exercise · Restricted Stock Units | −57,339 | 172,019 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2024-03-04 | Grant or award · Restricted Stock Units | +175,926 | 175,926 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2024-03-04 | Grant or award · Performance-Based Restricted Stock Units | +351,852 | 351,852 | D | ||
Loading xslF345X05/wk-form4_1709675759.xml…